Related Experiment Video
Updated: Jul 9, 2026
23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
How can developing countries harness biotechnology to improve health?
Abdallah S Daar1, Kathryn Berndtson, Deepa L Persad
1The Program on Life Sciences, Ethics and Policy of the McLaughlin-Rotman Centre for Global Health, University Health Network | McLaughlin Centre for Molecular Medicine, University of Toronto, Ontario, Canada. a.daar@utoronto.ca
BMC Public Health
|December 7, 2007
Summary
Developing countries need to build biotechnology capacity to address local health needs and combat neglected diseases. Recommendations focus on science, finance, ethics, and politics to harness genomics for global health equity.
Area of Science:
- Genomics and biotechnology applications in global health.
- Bridging the gap in health innovation between industrialized and developing nations.
Background:
- Genomics and biotechnology benefits are unevenly distributed, primarily favoring industrialized nations.
- The potential of biotechnology to address neglected diseases in developing regions remains largely untapped.
- A disparity in biotechnology capacity risks widening the global health inequity.
Purpose of the Study:
- To assess the potential of genomics to address health needs in the developing world.
- To explore strategies for harnessing genomics and biotechnology to improve health outcomes in developing regions.
- To analyze recommendations from developing world experts on advancing biotechnology for public health.
Main Methods:
- Organized five courses on Genomics and Public Health Policy in the developing world.
- Gathered and analyzed recommendations from 232 developing world experts across 58 countries.
- Categorized recommendations into four key areas: science, finance, ethics/society/culture, and politics.
Main Results:
- Recommendations emphasize collaboration through national, regional, and international networks.
- Financial strategies include developing regulatory frameworks, enhancing funding, and improving academic-industry interfaces.
- Ethical, social, and cultural considerations require public engagement and improved accessibility.
- Political strategies focus on strengthening leadership and developing national biotechnology strategies.
Conclusions:
- Empowering developing countries requires building local biotechnology capacity and addressing health needs.
- Implementing recommendations across sectors can help harness biotechnology and genomics for underserved populations.
- Global health equity can be advanced by empowering developing nations to utilize biotechnology for their citizens.
Related Concept Videos
01:59Plant Breeding and Biotechnology
Crop cultivation has a long history in human civilization, with records showing the cultivation of cereal plants beginning at around 8000 BC. This early plant breeding was developed primarily to provide a steady supply of food.
01:20The Central Dogma
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
01:09Recombinant DNA
Overview
01:26Methods Of Healthcare Delivery System
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
02:55Synthetic Biology
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
Golden rice
Golden rice is a genetically modified...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.